What is NDC 50090-8055?

50090-8055 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 3 package NDCs, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxazosin?

106 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxazosin NDC 50090-8055 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-8055Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-8055Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50090-8055-0	5009080550050090805500	30 TABLET in 1 BOTTLE (50090-8055-0)Marketed from Sep 14, 2026
50090-8055-1	5009080550150090805501	100 TABLET in 1 BOTTLE (50090-8055-1)Marketed from Sep 14, 2026
50090-8055-2	5009080550250090805502	90 TABLET in 1 BOTTLE (50090-8055-2)Marketed from Sep 14, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxazosin
Generic name (nonproprietary): doxazosin
Active ingredients: Doxazosin mesylate — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205210
Marketing start: Feb 13, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 50090-8055_51d7e507-0e37-4afb-96de-9fb1d266d6dcSPL ID 51d7e507-0e37-4afb-96de-9fb1d266d6dc
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090805500 followed by a unit qualifier and the quantity

Package 50090-8055-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 50090-8055

What is NDC 50090-8055?: 50090-8055 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxazosin.
What is the active ingredient?: Doxazosin mesylate.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin?: 106 other product NDCs are listed under this name. See all Doxazosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-166	16571-0166-01
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-165	16571-0165-01
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-167	16571-0167-01
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-168	16571-0168-01
Doxazosindoxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Aurobindo Pharma Limited	59651-892	59651-0892-0159651-0892-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Aurobindo Pharma Limited	59651-893	59651-0893-0159651-0893-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Aurobindo Pharma Limited	59651-894	59651-0894-0159651-0894-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Aurobindo Pharma Limited	59651-895	59651-0895-0159651-0895-99
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4031	70518-4031-00
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-3965	70518-3965-0070518-3965-01

All 107 Doxazosin NDCs

Other NDCs under ANDA 205210

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205210
Product	Strength	Form · route	Labeler	Product NDC
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-092
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-093
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-094
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-095
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	A-S Medication Solutions	50090-8097
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Golden State Medical Supply, Inc.	84677-044
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Golden State Medical Supply, Inc.	84677-045
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Golden State Medical Supply, Inc.	84677-046
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Golden State Medical Supply, Inc.	84677-047